The Use of Adenosine to Enable Safe Implantation of Transcatheter Tricuspid Valve

High precision is necessary during percutaneous transcatheter heart valve implantation. The precision of the implantation has been established by increasing the heart rate (usually to 200 beats per minute) to the point of significantly reduced cardiac output and thus minimizing valve movement. Routinely, this tachycardia is induced by rapid pacing. Here we report a case of failure to pace during valve-in-valve (VIV) Edwards Sapien XT implantation in the tricuspid valve position. Transient cardiac arrest was induced by intravenous adenosine injection enabling accurate valve implantation.

Download Full-text

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

The Thoracic and Cardiovascular Surgeon Reports ◽

10.1055/s-0037-1606345 ◽

2017 ◽

Vol 06 (01) ◽

pp. e29-e31 ◽

Cited By ~ 2

Author(s):

Daniel Reichart ◽

Niklas Schofer ◽

Florian Deuschl ◽

Andreas Schaefer ◽

Stefan Blankenberg ◽

...

Keyword(s):

United States ◽

Aortic Valve ◽

Tricuspid Valve ◽

Transcatheter Aortic Valve ◽

Transcatheter Heart Valve ◽

Risk Patients ◽

Valve Position ◽

Valve In Valve ◽

Valve Implantation ◽

Surgical Valve Replacement

Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.

Download Full-text

Jailing of a Pacemaker Lead During Tricuspid Valve-in-Valve Implantation With an Edwards SAPIEN XT Transcatheter Heart Valve

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2015.01.037 ◽

2015 ◽

Vol 31 (6) ◽

pp. 819.e9-819.e11 ◽

Cited By ~ 6

Author(s):

Jean-Michel Paradis ◽

Mathieu Bernier ◽

Christine Houde ◽

Éric Dumont ◽

Daniel Doyle ◽

...

Keyword(s):

Heart Valve ◽

Tricuspid Valve ◽

Pacemaker Lead ◽

Transcatheter Heart Valve ◽

Edwards Sapien ◽

Valve In Valve ◽

Valve Implantation

Download Full-text

Transseptal mitral valve-in-valve implantation in a degenerated mitral bioprosthesis: a case report and literature review

10.22541/au.161227482.21263815/v1 ◽

2021 ◽

Author(s):

Nils Perrin ◽

Hajo Muller ◽

Stephane Noble

Keyword(s):

Mitral Valve ◽

Literature Review ◽

Left Ventricular ◽

Left Ventricular Ejection ◽

Ventricular Ejection Fraction ◽

Transcatheter Heart Valve ◽

Edwards Sapien ◽

Valve In Valve ◽

Valve Implantation ◽

Mitral Bioprosthesis

We present hereby the case of a 75-year-old woman with a degenerated mitral bioprosthesis and severely reduced left ventricular ejection fraction who underwent a successful trans-septal mitral valve-in-valve (TMViV) replacement using a 29mm Edwards Sapien S3 transcatheter heart valve. We also performed a literature review.

Download Full-text

Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

Texas Heart Institute Journal ◽

10.14503/thij-14-4302 ◽

2014 ◽

Vol 41 (5) ◽

pp. 507-510 ◽

Cited By ~ 9

Author(s):

Ali Mortazavi ◽

Ross M. Reul ◽

Leon Cannizzaro ◽

Kathryn G. Dougherty

Keyword(s):

Tricuspid Valve ◽

Shortness Of Breath ◽

Tricuspid Valve Replacement ◽

Thoracic Surgical Procedures ◽

Edwards Sapien ◽

Cardiology Clinic ◽

History Of ◽

Valve In Valve ◽

Transcatheter Valve ◽

Valve Implantation

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.

Download Full-text

Valve-in-Valve in the Tricuspid Position for a Stenosed Bioprosthesis

The Heart Surgery Forum ◽

10.1532/hsf98.20121106 ◽

2015 ◽

Vol 16 (2) ◽

pp. 96 ◽

Cited By ~ 5

Author(s):

Ziv Beckerman ◽

Oved Cohen ◽

Arthur Kerner ◽

Ariel Roguin ◽

Avishai Ziser ◽

...

Keyword(s):

Cardiac Surgery ◽

Tricuspid Valve ◽

Open Heart ◽

Technical Feasibility ◽

Edwards Sapien ◽

Valve In Valve ◽

Transcatheter Valve ◽

Valve Implantation ◽

Bioprosthetic Valves ◽

Surgery In Elderly

The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.

Download Full-text